- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03238820
Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study
July 31, 2017 updated by: JIANG Zhi-Wei
Patients with gastric gastrointestinal stromal tumors will receive robotic resection.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Gastrointestinal stromal tumors are the most common stromal tumors of the digestive tract.
Approximately 60% of tumors develop in the stomach.Before, patients with gastric gastrointestinal stromal tumors would receive open or laparoscopic surgery.
However, gastrointestinal stromal tumors located at special sites, such as cardia, were hardly treated.
Recently, the robot was used to remove gastric gastrointestinal stromal tumors.
In this study, the robot will be used to remove gastric gastrointestinal stromal tumors.
Then, we will evaluate the effect of robotic gastric gastrointestinal stromal tumors resection.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210002
- Jinling Hospital, Medical School of Nanjing University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Requirements of informed consent and assent of participant, parent or legal guardian as applicable.
- Patients with gastric gastrointestinal stromal tumors scheduled for robotic resection and between the age of 18 and 80 years old without considering sex.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Participants can follow the visit plan.
Exclusion Criteria:
- Patients certified by a doctor that doesn't fit to participate in this study.
- Patients with ischemic heart disease, cerebrovascular disease and peripheral vascular disease, or their cardiac function > II (NYHA) patients, patients received coronary artery bypass grafting (CABG) recently, and patients with severe hypertension (systolic pressure≥180mmHg or diastolic pressure≥110mmHg).
- Patients with gastrointestinal stromal tumor with distant metastasis.
- Patients with severe infection, respiratory dysfunction, coagulation disorders, severe liver and renal dysfunction (Child - Pugh≥ 10; creatinine clearance < 25 ml/min).
- Patients with gastrointestinal operations and complicated abdominal operations.
- Patients with severe malnutrition (albumin≤30g/L, weight loss in half a year>10%, Subjective Global Assessment (SGA) classification C, body mass index <18, Hb<70g/L).
- Pregnancy and lactation women, or have a pregnancy plan within a month after the test of the subjects (also including male participants).
- Patients participated other subjects 3 months before this subject.
- Sponsors or researchers directly involved in the testing or their family members.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: The robot group
Patients undergo robotic gastric gastrointestinal stromal tumors resection.
|
Robotic gastric gastrointestinal stromal tumors resection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complications
Time Frame: 1 month
|
Intraoperative and postoperative complications
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operative time
Time Frame: 1 day
|
Operative time
|
1 day
|
Postoperative length of stay
Time Frame: 1 month
|
Postoperative length of stay
|
1 month
|
Blood loss
Time Frame: 1 day
|
Blood loss
|
1 day
|
Resection style
Time Frame: 1 day
|
The wedge resection, gastrotomy, partial gastrectomy and total gastrectomy were selected based on tumor size and site.
|
1 day
|
Inflammation level
Time Frame: 1 month
|
Inflammation level
|
1 month
|
Nutritional status
Time Frame: 6 months
|
Nutritional status
|
6 months
|
Body composition
Time Frame: 6 months
|
Body composition
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 10, 2014
Primary Completion (Actual)
August 5, 2016
Study Completion (Actual)
June 1, 2017
Study Registration Dates
First Submitted
July 27, 2017
First Submitted That Met QC Criteria
July 31, 2017
First Posted (Actual)
August 3, 2017
Study Record Updates
Last Update Posted (Actual)
August 3, 2017
Last Update Submitted That Met QC Criteria
July 31, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BE2015687GIST
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
The results and IPD might be considered to share in published articles.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Stromal Tumor of Stomach
-
Hospital Universitario Virgen de la ArrixacaNot yet recruitingLiver Diseases | Liver Transplantation | Liver Neoplasms | Gastrointestinal Stromal Tumors | Metastasis | Liver Metastases | Liver Transplant; Complications | Liver Cancer | Liver Transplant Disorder | Liver Carcinoma | GIST, Malignant | GIST | Metastases | Metastatic Liver Cancer | Gastrointestinal Stromal Tumor of... and other conditionsSpain
-
GEM Hospital & Research CenterCompletedGastric GIST | Submucosal Tumor of Stomach
-
Pamela L. KunzGenentech, Inc.CompletedStomach Cancer | Gastrointestinal Stromal Tumor (GIST) | Gastric (Stomach) Cancer | Neoplasm of Cardioesophageal JunctionUnited States
-
Stanford UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingGastrointestinal Diseases | Gastrointestinal Stromal Tumor (GIST) | Gastric (Stomach) CancerUnited States
-
National Cancer Center, KoreaUnknownSubmucosal Tumor of StomachKorea, Republic of
-
Stanford UniversityNational Institutes of Health (NIH)RecruitingStomach Cancer | Esophageal Cancer | Gastrointestinal Stromal Tumor (GIST) | Gastric (Stomach) Cancer | Gastro-Esophageal(GE) Junction CancerUnited States
-
Universitätsklinikum Hamburg-EppendorfOvesco Endoscopy AGSuspendedSubmucosal Tumor of StomachGermany
-
Centre Leon BerardRecruitingMetastatic Gastrointestinal Stromal Tumor | Unresectable Gastrointestinal Stromal Tumor (GIST) | Locally Advanced Gastrointestinal Stromal Tumor (GIST)France
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Gastrointestinal Stromal Tumor | Metastatic Sarcoma | Locally Advanced Sarcoma | Locally Advanced Gastrointestinal Stromal Tumor | Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 | Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal... and other conditionsUnited States
-
Aesculap AGB.Braun Surgical SAWithdrawnGastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Digestive System Neoplasm | Rectum Tumor | Stomach Tumor | Colon Tumor | Small Intestine TumorSpain
Clinical Trials on Robotic gastric gastrointestinal stromal tumors resection
-
Anderson Clinical ResearchLigand PharmaceuticalsCompletedHIV Infections | Sarcoma, Kaposi
-
Sichuan Provincial People's HospitalRecruitingGastrointestinal Stromal Tumor(GIST)China
-
University of PatrasCompletedMorbid ObesityGreece
-
Muhimbili University of Health and Allied SciencesKarolinska InstitutetCompletedInstantaneous ClearanceTanzania
-
Lisa BarrettNova Scotia Health Authority; Dalhousie UniversityActive, not recruiting
-
Shanghai Zhongshan HospitalEastern Hepatobiliary Surgery Hospital; Xinhua Hospital, Shanghai Jiao Tong... and other collaboratorsUnknownLiver Cirrhosis | Portal Vein ThrombosisChina
-
Eisai Co., Ltd.CompletedCervical Dystonia | Spasmodic TorticollisJapan
-
Onze Lieve Vrouwe GasthuisCompletedKidney Failure, AcuteNetherlands
-
University Hospitals Bristol and Weston NHS Foundation...CompletedLung Metastases | Lung TumourUnited Kingdom
-
Xue-chun LuRecruiting